Andreas Struengmann & family net worth
Current Net Worth – $13.3 Billion (USD – 1,330 Crores), (Rupees – 1.03 Lakh Crores)
Andreas Struengmann short biography
|Net Worth||$13.3 Billion|
|Born||1950 (Age – 71)|
|Identified as||Founder of Hexal AG|
|Education||University at Buffalo, Medical Doctor|
Andreas Strüngmann has a net worth of $13.3 Billion (Rupees – 1,03,498 Crores), making him one of the richest men in the world.
He is a German entrepreneur who started Hexal AG in 1986.
It surpassed Pfizer as Germany’s second-largest generic medication manufacturer.
You may also like:
Andreas Struengmann biography
|Full Name||Andreas Struengmann|
|Height||6.0 feet, 182 cm|
Andreas Struengmann was born in 1950 and now he is 71 years old.
Andreas Struengmann and his twin brother Thomas sold Hexal to Novartis for $7 billion in 2005.
In 1986, they co-founded Hexal. Simvastatin, a competitor to Merck’s ZOCOR, was introduced as a highly effective cholesterol-lowering medicine.
They founded a neurological research facility in Frankfurt in 2008, which is named after their father, Ernst Struengmann.
He had graduated from the University at Buffalo and achieved a Medical Doctors degree.
He and his brother Thomas sold Hexal and their 67.7% stake in U.S. Eon Labs to Novartis for $7.5 billion in February 2005, establishing Sandoz the world’s largest generic-drug firm.
BioNTech from Germany and Mega Pharma from Uruguay, which began as a joint venture with Argentine millionaire Alberto Roemmers.
Santo Holding, situated in Zug, Switzerland, is where the brothers invest in biotech, pharma, life sciences, and healthcare firms.
Private & early life
He is married and has two children and presently lives in Tegernsee and South Africa.
He accepted an executive job at Sandoz, Novartis’ generics subsidiary, at the age of 56.
Net worth statistics
- March 2012 – $3.3 B
- March 2013 – $3.4 B
- March 2014 – $3.5 B
- March 2015 – $3.3 B
- March 2016 – $3.2 B
- March 2017 – $3.1 B
- March 2018 – $3.7 B
- March 2019 – $4.4 B
- April 2020 – $9.6 B
- April 2021 – $11.0 B
- April 2022 – $11.9 B